Skip to Content
Merck
  • Thin-layer chromatographic determination of major metamizole metabolites in serum and urine.

Thin-layer chromatographic determination of major metamizole metabolites in serum and urine.

Journal of chromatography (1983-05-13)
N Sistovaris, W Pola, H Wolhoff
ABSTRACT

Thin-layer chromatographic (TLC) methods were developed for pharmacokinetic studies of major metamizole metabolites in serum and urine. These methods proved practicable, selective, accurate and sensitive with detection limits as follows: 4-methylaminoantipyrine 0.6 micrograms/ml serum and 2.0 micrograms/ml urine; 4-aminoantipyrine 0.16 micrograms/ml serum and 1.0 micrograms/ml urine; 4-acetylaminoantipyrine 0.14 micrograms/ml serum and 0.6 micrograms/ml urine; 4-formylaminoantipyrine 0.12 micrograms/ml serum and 1.0 micrograms/ml urine. Samples of 250 microliter suffice for TLC analysis. Following chromatographic separation, detection is performed in the ultraviolet range at 265 nm. Serum and urine levels were determined following a single oral dose of 1 g of metamizole sodium to eight volunteers. These results were compared with those following an accidental overdose of 49 g.

MATERIALS
Product Number
Brand
Product Description

Metamizole impurity A, European Pharmacopoeia (EP) Reference Standard
Supelco
4-Formylaminoantipyrine, VETRANAL®, analytical standard